Antibiotic susceptibility signatures identify potential antimicrobial targets in the Acinetobacter baumannii cell envelope
- PMID: 32908144
- PMCID: PMC7481262
- DOI: 10.1038/s41467-020-18301-2
Antibiotic susceptibility signatures identify potential antimicrobial targets in the Acinetobacter baumannii cell envelope
Erratum in
-
Author Correction: Antibiotic susceptibility signatures identify potential antimicrobial targets in the Acinetobacter baumannii cell envelope.Nat Commun. 2020 Nov 24;11(1):6107. doi: 10.1038/s41467-020-20098-z. Nat Commun. 2020. PMID: 33235195 Free PMC article.
Abstract
A unique, protective cell envelope contributes to the broad drug resistance of the nosocomial pathogen Acinetobacter baumannii. Here we use transposon insertion sequencing to identify A. baumannii mutants displaying altered susceptibility to a panel of diverse antibiotics. By examining mutants with antibiotic susceptibility profiles that parallel mutations in characterized genes, we infer the function of multiple uncharacterized envelope proteins, some of which have roles in cell division or cell elongation. Remarkably, mutations affecting a predicted cell wall hydrolase lead to alterations in lipooligosaccharide synthesis. In addition, the analysis of altered susceptibility signatures and antibiotic-induced morphology patterns allows us to predict drug synergies; for example, certain beta-lactams appear to work cooperatively due to their preferential targeting of specific cell wall assembly machineries. Our results indicate that the pathogen may be effectively inhibited by the combined targeting of multiple pathways critical for envelope growth.
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Large-Scale Identification of AbaR-Type Genomic Islands in Acinetobacter baumannii Reveals Diverse Insertion Sites and Clonal Lineage-Specific Antimicrobial Resistance Gene Profiles.Antimicrob Agents Chemother. 2019 Mar 27;63(4):e02526-18. doi: 10.1128/AAC.02526-18. Print 2019 Apr. Antimicrob Agents Chemother. 2019. PMID: 30917986 Free PMC article.
-
Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA.BMC Infect Dis. 2016 May 4;16:194. doi: 10.1186/s12879-016-1526-y. BMC Infect Dis. 2016. PMID: 27146090 Free PMC article.
-
Genetic basis of antibiotic resistance in pathogenic Acinetobacter species.IUBMB Life. 2011 Dec;63(12):1061-7. doi: 10.1002/iub.532. Epub 2011 Oct 12. IUBMB Life. 2011. PMID: 21990280 Review.
-
Acinetobacter baumannii: an emerging multidrug-resistant threat.Expert Rev Anti Infect Ther. 2008 Jun;6(3):309-25. doi: 10.1586/14787210.6.3.309. Expert Rev Anti Infect Ther. 2008. PMID: 18588496 Review.
-
Whole-Genome Analysis of an Extensively Drug-Resistant Acinetobacter baumannii Strain XDR-BJ83: Insights into the Mechanisms of Resistance of an ST368 Strain from a Tertiary Care Hospital in China.Microb Drug Resist. 2018 Nov;24(9):1259-1270. doi: 10.1089/mdr.2017.0246. Epub 2018 Feb 28. Microb Drug Resist. 2018. PMID: 29489445
Cited by
-
DNA damage response coregulator ddrR affects many cellular pathways and processes in Acinetobacter baumannii 17978.Front Cell Infect Microbiol. 2024 Jan 11;13:1324091. doi: 10.3389/fcimb.2023.1324091. eCollection 2023. Front Cell Infect Microbiol. 2024. PMID: 38274737 Free PMC article.
-
Identification of essential genes that support fitness of Acinetobacter baumannii efflux pump overproducers in the presence of fluoroquinolone.bioRxiv [Preprint]. 2024 Jan 5:2024.01.04.574119. doi: 10.1101/2024.01.04.574119. bioRxiv. 2024. PMID: 38260615 Free PMC article. Preprint.
-
Chemical genetic approaches for the discovery of bacterial cell wall inhibitors.RSC Med Chem. 2023 Aug 30;14(11):2125-2154. doi: 10.1039/d3md00143a. eCollection 2023 Nov 15. RSC Med Chem. 2023. PMID: 37974958 Review.
-
Genome-scale analysis of essential gene knockout mutants to identify an antibiotic target process.Antimicrob Agents Chemother. 2023 Dec 14;67(12):e0110223. doi: 10.1128/aac.01102-23. Epub 2023 Nov 15. Antimicrob Agents Chemother. 2023. PMID: 37966228 Free PMC article.
-
Essential Gene Knockdowns Reveal Genetic Vulnerabilities and Antibiotic Sensitivities in Acinetobacter baumannii.bioRxiv [Preprint]. 2023 Aug 2:2023.08.02.551708. doi: 10.1101/2023.08.02.551708. bioRxiv. 2023. PMID: 37577569 Free PMC article. Updated. Preprint.
References
-
- Food and Drug Administration. Establishing a list of qualifying pathogens under the food and drug administration safety and innovation act. Fed. Register. 2013;78:35155–35173. - PubMed
-
- Tacconelli E, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect. Dis. 2018;18:318–327. - PubMed
-
- CDC. Antibiotic Resistance Threats in the United States, 2019. 64–68. https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-re... (2019).
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
